Market closedNon-fractional
Hologic/HOLX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Hologic
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Ticker
HOLX
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Marlborough, United States
Employees
6,990
Website
www.hologic.com
Hologic Metrics
BasicAdvanced
$18B
Market cap
40.85
P/E ratio
$1.91
EPS
0.99
Beta
-
Dividend rate
Price and volume
Market cap
$18B
Beta
0.99
Financial strength
Current ratio
3.969
Quick ratio
2.97
Long term debt to equity
51.897
Total debt to equity
52.669
Interest coverage (TTM)
7.92%
Management effectiveness
Return on assets (TTM)
6.22%
Return on equity (TTM)
9.20%
Valuation
Price to earnings (TTM)
40.847
Price to revenue (TTM)
4.752
Price to book
3.8
Price to tangible book (TTM)
23
Price to free cash flow (TTM)
19.832
Growth
Revenue change (TTM)
-2.37%
Earnings per share change (TTM)
-36.42%
3-year revenue growth (CAGR)
-9.35%
3-year earnings per share growth (CAGR)
-36.02%
What the Analysts think about Hologic
Analyst Ratings
Majority rating from 18 analysts.
Hologic Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$1B
0.46%
Net income
$170M
-31.08%
Profit margin
16.69%
-31.40%
Hologic Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Actual
$0.93
$0.89
$0.98
$1.03
-
Expected
$0.89
$0.84
$0.95
$0.98
$1.02
Surprise
4.43%
5.86%
3.03%
5.37%
-
Hologic News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Hologic stock?
Hologic (HOLX) has a market cap of $18B as of July 27, 2024.
What is the P/E ratio for Hologic stock?
The price to earnings (P/E) ratio for Hologic (HOLX) stock is 40.85 as of July 27, 2024.
Does Hologic stock pay dividends?
No, Hologic (HOLX) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Hologic dividend payment date?
Hologic (HOLX) stock does not pay dividends to its shareholders.
What is the beta indicator for Hologic?
Hologic (HOLX) has a beta rating of 0.99. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Hologic stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.